U.S. markets open in 9 hours 7 minutes
  • S&P Futures

    3,831.50
    -2.50 (-0.07%)
     
  • Dow Futures

    30,910.00
    -26.00 (-0.08%)
     
  • Nasdaq Futures

    11,809.50
    +1.00 (+0.01%)
     
  • Russell 2000 Futures

    1,738.40
    -3.30 (-0.19%)
     
  • Crude Oil

    99.87
    +0.37 (+0.37%)
     
  • Gold

    1,767.00
    +3.10 (+0.18%)
     
  • Silver

    19.03
    -0.09 (-0.48%)
     
  • EUR/USD

    1.0260
    -0.0011 (-0.10%)
     
  • 10-Yr Bond

    2.8090
    -0.0800 (-2.77%)
     
  • Vix

    27.54
    +0.01 (+0.04%)
     
  • GBP/USD

    1.1952
    +0.0001 (+0.00%)
     
  • USD/JPY

    135.4730
    -0.3690 (-0.27%)
     
  • BTC-USD

    20,154.56
    -55.14 (-0.27%)
     
  • CMC Crypto 200

    436.90
    -3.13 (-0.71%)
     
  • FTSE 100

    7,025.47
    -207.18 (-2.86%)
     
  • Nikkei 225

    26,121.14
    -302.33 (-1.14%)
     

New Strong Sell Stocks for March 1st

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:

Agios Pharmaceuticals AGIO: is a biopharmaceutical company focused on development of treatments for rare genetic metabolic disorders, a subset of orphan genetic metabolic diseases. The Zacks Consensus Estimate for its current year earnings has been revised 26.6% downward over the last 60 days.

Alimera Sciences ALIM: is a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. The Zacks Consensus Estimate for its current year earnings has been revised 302.1% downward over the last 60 days.

BrightView (BV): is a provider of commercial landscaping services primarily in the United States. The Zacks Consensus Estimate for its current year earnings has been revised almost 7.4% downward over the last 60 days.

View the entire Zacks Rank #5 List.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Alimera Sciences, Inc. (ALIM) : Free Stock Analysis Report
 
Agios Pharmaceuticals, Inc. (AGIO) : Free Stock Analysis Report
 
BrightView Holdings, Inc. (BV) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research